CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-30 | Ramasastry Saira Director | Grant or award | +8,000 | 18,619 | ||
| 2024-05-30 | Ramasastry Saira Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2024-05-30 | NELSEN ROBERT Director | Grant or award | +8,000 | 584,148 | ||
| 2024-05-30 | NELSEN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2024-05-30 | Napolitano Janet Director | Grant or award | +8,000 | 23,806 | ||
| 2024-05-30 | Napolitano Janet Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2024-05-30 | MORE ROBERT J Director | Grant or award | +8,000 | 46,683 | ||
| 2024-05-30 | MORE ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2024-05-30 | Hatfield Jeffrey S. Director | Grant or award | +8,000 | 23,806 | ||
| 2024-05-30 | Hatfield Jeffrey S. Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2024-05-29 | Farid Ramy Director | Grant or award | +16,000 | 16,000 | ||
| 2024-05-29 | Farid Ramy Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2024-05-29 | Farid Ramy Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2024-05-29 | BISCHOFBERGER NORBERT W Director | Grant or award | +16,000 | 16,000 | ||
| 2024-05-29 | BISCHOFBERGER NORBERT W Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2024-05-29 | BISCHOFBERGER NORBERT W Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2024-04-03 | De Backer Marianne Chief Executive Officer | Sale 10b5-1 | −72,995 | $9.46 | $690K | 678,457 |
| 2024-04-01 | HANLY ANN M. EVP & Chief Technology Officer | Sale 10b5-1 | −2,711 | $10.05 | $27K | 132,069 |
| 2024-03-27 | Lee Sung EVP & Chief Financial Officer | Sale | −6,008 | $9.89 | $59K | 100,492 |
| 2024-02-26 | SCANGOS GEORGE A Director | Sale 10b5-1 | −17,722 | $11.65 | $207K | 112,989 |
Page 9 of 54 · 1,063 trades